(Total Views: 684)
Posted On: 12/09/2020 9:22:01 PM
Post# of 37
$RVVTF (copy) DD by FRESS Potential Emergency Use Authorization.
commercial readiness and
manufacturing scale-up underway.
Bucillamine phase 3 CV-19 mild-moderate cases 80% data Dec 2020
OTC Peers Valuations phase 3 or psilocybin
CYDY 1.7 Billion ph 3 CV
RLFTF 1.2 Billion ph 3CV
Mindmed 900 million+ Phase 2 psilocybin
RVVTF 70 million late stage ph 3 drug that has low side effects & can scale quantities distribution is in place.
https://clinicaltrials.gov/ct2/show/NCT04504734
commercial readiness and
manufacturing scale-up underway.
Bucillamine phase 3 CV-19 mild-moderate cases 80% data Dec 2020
OTC Peers Valuations phase 3 or psilocybin
CYDY 1.7 Billion ph 3 CV
RLFTF 1.2 Billion ph 3CV
Mindmed 900 million+ Phase 2 psilocybin
RVVTF 70 million late stage ph 3 drug that has low side effects & can scale quantities distribution is in place.
https://clinicaltrials.gov/ct2/show/NCT04504734
(0)
(0)
$MJ
